Cargando…

Advances in breast cancer screening modalities and status of global screening programs

Breast cancer (BC) is the most prevalent malignancy worldwide, and a continued upward trend has been predicted in the coming decades. Screening in selected targeted populations, which is effective in reducing cancer‐related mortality, has been widely implemented in many countries. This review summar...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Chenyu, Wang, Le, Zhang, Yuhan, Lu, Ming, Lu, Bin, Cai, Jie, Chen, Hongda, Dai, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215717/
https://www.ncbi.nlm.nih.gov/pubmed/35774423
http://dx.doi.org/10.1002/cdt3.21
_version_ 1784731268495179776
author Luo, Chenyu
Wang, Le
Zhang, Yuhan
Lu, Ming
Lu, Bin
Cai, Jie
Chen, Hongda
Dai, Min
author_facet Luo, Chenyu
Wang, Le
Zhang, Yuhan
Lu, Ming
Lu, Bin
Cai, Jie
Chen, Hongda
Dai, Min
author_sort Luo, Chenyu
collection PubMed
description Breast cancer (BC) is the most prevalent malignancy worldwide, and a continued upward trend has been predicted in the coming decades. Screening in selected targeted populations, which is effective in reducing cancer‐related mortality, has been widely implemented in many countries. This review summarizes the advances in BC screening techniques, organized or opportunistic BC screening programs across different countries, and screening modalities recommended by different academic authorities. Mammography is the most widely used and effective technique for BC screening. Other complementary techniques include ultrasound, clinical breast examination, and magnetic resonance imaging. Novel screening tests, including digital breast tomosynthesis and liquid biopsies, are still under development. Globally, the implementation status of BC screening programs is uneven, which is reflected by differences in screening modes, techniques, and population coverage. The recommended optimal screening strategies varied according to the authoritative guidelines. The effectiveness of current screening programs is influenced by several factors, including low detection rate, high false‐positive rate, and unsatisfactory coverage and uptake rates. Exploration of accurate BC risk prediction models and the development of risk‐stratified screening strategies are highly warranted in future research.
format Online
Article
Text
id pubmed-9215717
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92157172022-06-29 Advances in breast cancer screening modalities and status of global screening programs Luo, Chenyu Wang, Le Zhang, Yuhan Lu, Ming Lu, Bin Cai, Jie Chen, Hongda Dai, Min Chronic Dis Transl Med Reviews Breast cancer (BC) is the most prevalent malignancy worldwide, and a continued upward trend has been predicted in the coming decades. Screening in selected targeted populations, which is effective in reducing cancer‐related mortality, has been widely implemented in many countries. This review summarizes the advances in BC screening techniques, organized or opportunistic BC screening programs across different countries, and screening modalities recommended by different academic authorities. Mammography is the most widely used and effective technique for BC screening. Other complementary techniques include ultrasound, clinical breast examination, and magnetic resonance imaging. Novel screening tests, including digital breast tomosynthesis and liquid biopsies, are still under development. Globally, the implementation status of BC screening programs is uneven, which is reflected by differences in screening modes, techniques, and population coverage. The recommended optimal screening strategies varied according to the authoritative guidelines. The effectiveness of current screening programs is influenced by several factors, including low detection rate, high false‐positive rate, and unsatisfactory coverage and uptake rates. Exploration of accurate BC risk prediction models and the development of risk‐stratified screening strategies are highly warranted in future research. John Wiley and Sons Inc. 2022-05-25 /pmc/articles/PMC9215717/ /pubmed/35774423 http://dx.doi.org/10.1002/cdt3.21 Text en © 2022 The Authors. Chronic Diseases and Translational Medicine published by John Wiley & Sons Ltd on behalf of Chinese Medical Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Reviews
Luo, Chenyu
Wang, Le
Zhang, Yuhan
Lu, Ming
Lu, Bin
Cai, Jie
Chen, Hongda
Dai, Min
Advances in breast cancer screening modalities and status of global screening programs
title Advances in breast cancer screening modalities and status of global screening programs
title_full Advances in breast cancer screening modalities and status of global screening programs
title_fullStr Advances in breast cancer screening modalities and status of global screening programs
title_full_unstemmed Advances in breast cancer screening modalities and status of global screening programs
title_short Advances in breast cancer screening modalities and status of global screening programs
title_sort advances in breast cancer screening modalities and status of global screening programs
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215717/
https://www.ncbi.nlm.nih.gov/pubmed/35774423
http://dx.doi.org/10.1002/cdt3.21
work_keys_str_mv AT luochenyu advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms
AT wangle advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms
AT zhangyuhan advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms
AT luming advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms
AT lubin advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms
AT caijie advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms
AT chenhongda advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms
AT daimin advancesinbreastcancerscreeningmodalitiesandstatusofglobalscreeningprograms